Showing 2821-2830 of 5909 results for "".
- New Peer-Reviewed Paper Offers Advice to Contact Lens Practitioners During COVID-19 Pandemichttps://modernod.com/news/new-peer-reviewed-paper-offers-advice-to-contact-lens-practitioners-during-covid-19-pandemic/2477569/A new peer-reviewed paper from five prominent ocular scientists aims to help eye care practitioners (ECPs) instruct and reassure contact lens wearers during the global COVID-19 pandemic. Published in Contact Lens & Anterior Eye,
- Contact Lens Institute Shares New CDC Guidance for Contact Lens Wear and COVID-19https://modernod.com/news/contact-lens-institute-shares-new-cdc-guidance-for-contact-lens-wear-and-covid-19/2477563/The Contact Lens Institute is sharing new guidance issued this week by the U.S. Centers for Disease Control and Prevention (CDC) regarding contact lens wear and care amid the COVID-19 pandemic. The direction,
- Pfizer Aims to Start Clinical Testing of Lead Compound Against SARS-CoV-2 in Third Quarterhttps://modernod.com/news/pfizer-aims-to-start-clinical-testing-of-lead-compound-against-sars-cov-2-in-third-quarter/2477560/In an update on its efforts to combat COVID-19, Pfizer said results of initial screening assays have led it to zero in on a lead protease inhibitor with antiviral activity against SARS-CoV-2 based on preliminary data. The company stated that it will now perform preclinical testing on the compound
- LambdaVision Wins NASA Award to Further Advance Development of an Artificial Retinahttps://modernod.com/news/lambdavision-wins-nasa-award-to-further-advance-development-of-an-artificial-retina/2477556/LambdaVision, along with implementation partner, Space Tango, has been selected by NASA for an award of $5 million. This new funding will support LambdaVision’s development of the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significan
- GlaxoSmithKline Takes $250 Million Stake in Vir as Companies Pair Up to Develop Coronavirus Treatmentshttps://modernod.com/news/glaxosmithkline-takes-250-million-stake-in-vir-as-companies-pair-up-to-develop-coronavirus-treatments/2477536/GlaxoSmithKline and Vir Biotechnology announced that they have agreed to enter into a collaboration to develop anti-viral antibodies for coronaviruses, including SARS-CoV-2. In addition, to gain access to Vir’s monoclonal antibody technology, GlaxoSmithKline said it will also make an equity
- FDA Issues New Policy for Remote Ophthalmic Assessment and Monitoring Devices During COVID-19https://modernod.com/news/fda-issues-new-policy-for-remote-ophthalmic-assessment-and-monitoring-devices-during-covid-19/2477535/The FDA issued immediate guidance to help expand the capability of remote ophthalmic assessment and monitoring devices. These devices include visual acuity charts, visual field devices, general use ophthalmic cameras, and tonometers. This guidance is intended to help facilitate patient c
- Iveric bio Announces Fast Track Designation From FDA for Zimura for Treatment of Geographic Atrophy Secondary to Dry AMDhttps://modernod.com/news/iveric-bio-announces-fast-track-designation-from-fda-for-zimura-for-treatment-of-geographic-atrophy-secondary-to-dry-amd/2477528/Iveric bio announced that the FDA has granted Fast Track designation to Zimura (avacincaptad pegol), a novel complement C5 inhibitor, in development for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). Currently, there is no FDA or EMA appro
- Prevent Blindness Provides Free Eye Health Curriculum to Educators to Help Children Learn About Importance of Eye Carehttps://modernod.com/news/prevent-blindness-provides-free-eye-health-curriculum-to-educators-to-help-children-learn-about-importance-of-eye-care/2477518/Schools and educational facilities across the country are now closed due to the COVID-19 pandemic. Many educators, public health and non-profit groups are looking for quality, no-cost educational materials to support remote learning for children. Prevent Blindness is offering the
- FDA Launches Program to Speed Development of COVID-19 Treatmentshttps://modernod.com/news/fda-launches-program-to-speed-development-of-covid-19-treatments/2477511/The FDA unveiled a new initiative, dubbed the “Coronavirus Treatment Acceleration Programme (CTAP),” designed to expedite the development of effective treatments for patients with COVID-19. Alex Azar, secretary of the US Department of Health and Human Services, said that “as par
- Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19https://modernod.com/news/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19/2477489/Johnson & Johnson announced a $1 billion deal with the U.S. government to create enough manufacturing capacity to make more than 1 billion doses of a potential vaccine for COVID-19. Johnson & Johnson said on Monday it has been working on a vaccine since January 2020 and expects to initiat